155 related articles for article (PubMed ID: 29063699)
21. Case report of a rare purine synthesis disorder due to 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICAR) deficiency.
Joy P; Madhuri V; Palocaren T; Das S; Susan Cleave Abraham S; Korula S; Koshy B; Jose J; Chandran M; Danda S
Brain Dev; 2022 Oct; 44(9):645-649. PubMed ID: 35637059
[TBL] [Abstract][Full Text] [Related]
22. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I
Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863
[TBL] [Abstract][Full Text] [Related]
23. Analysis of substrate binding in individual active sites of bifunctional human ATIC.
Witkowska D; Cox HL; Hall TC; Wildsmith GC; Machin DC; Webb ME
Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):254-263. PubMed ID: 29042184
[TBL] [Abstract][Full Text] [Related]
24. Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk.
Gellekink H; Blom HJ; den Heijer M
Clin Chem Lab Med; 2007; 45(4):471-6. PubMed ID: 17439323
[TBL] [Abstract][Full Text] [Related]
25. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
26. Identification of ATIC as a Novel Target for Chemoradiosensitization.
Liu X; Paila UD; Teraoka SN; Wright JA; Huang X; Quinlan AR; Gatti RA; Concannon P
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):162-173. PubMed ID: 29029884
[TBL] [Abstract][Full Text] [Related]
27. Structure and functional relationships in human pur H.
Beardsley GP; Rayl EA; Gunn K; Moroson BA; Seow H; Anderson KS; Vergis J; Fleming K; Worland S; Condon B; Davies J
Adv Exp Med Biol; 1998; 431():221-6. PubMed ID: 9598063
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of AICAR transformylase IMP cyclohydrolase (TM1249) from Thermotoga maritima at 1.88 A resolution.
Axelrod HL; McMullan D; Krishna SS; Miller MD; Elsliger MA; Abdubek P; Ambing E; Astakhova T; Carlton D; Chiu HJ; Clayton T; Duan L; Feuerhelm J; Grzechnik SK; Hale J; Han GW; Haugen J; Jaroszewski L; Jin KK; Klock HE; Knuth MW; Koesema E; Morse AT; Nigoghossian E; Okach L; Oommachen S; Paulsen J; Quijano K; Reyes R; Rife CL; van den Bedem H; Weekes D; White A; Wolf G; Xu Q; Hodgson KO; Wooley J; Deacon AM; Godzik A; Lesley SA; Wilson IA
Proteins; 2008 May; 71(2):1042-9. PubMed ID: 18260100
[No Abstract] [Full Text] [Related]
29. 5-Amino-4-Imidazolecarboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase Polymorphisms Affect the Susceptibility to Multiple Myeloma.
Wang Y; Ling Z; Hu Z; Gui Y; Huang C; Yao Y; Li R
Lab Med; 2022 Sep; 53(5):465-474. PubMed ID: 35397004
[TBL] [Abstract][Full Text] [Related]
30. AICA-ribosiduria due to ATIC deficiency: Delineation of the phenotype with three novel cases, and long-term update on the first case.
Ramond F; Rio M; Héron B; Imbard A; Marie S; Billiemaz K; Denommé-Pichon AS; Kuentz P; Ceballos I; Piraud M; Vincent MF; Touraine R
J Inherit Metab Dis; 2020 Nov; 43(6):1254-1264. PubMed ID: 32557644
[TBL] [Abstract][Full Text] [Related]
31. Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors.
Li C; Xu L; Wolan DW; Wilson IA; Olson AJ
J Med Chem; 2004 Dec; 47(27):6681-90. PubMed ID: 15615517
[TBL] [Abstract][Full Text] [Related]
32. Targeting tumour proliferation with a small-molecule inhibitor of AICAR transformylase homodimerization.
Spurr IB; Birts CN; Cuda F; Benkovic SJ; Blaydes JP; Tavassoli A
Chembiochem; 2012 Jul; 13(11):1628-34. PubMed ID: 22764122
[TBL] [Abstract][Full Text] [Related]
33. Characterization of two 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase isozymes from Saccharomyces cerevisiae.
Tibbetts AS; Appling DR
J Biol Chem; 2000 Jul; 275(27):20920-7. PubMed ID: 10877846
[TBL] [Abstract][Full Text] [Related]
34. 5-Aminoimidazole-4-carboxamide ribotide transformylase-IMP cyclohydrolase from human CCRF-CEM leukemia cells: purification, pH dependence, and inhibitors.
Szabados E; Hindmarsh EJ; Phillips L; Duggleby RG; Christopherson RI
Biochemistry; 1994 Nov; 33(47):14237-45. PubMed ID: 7947835
[TBL] [Abstract][Full Text] [Related]
35. The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network.
Boutchueng-Djidjou M; Collard-Simard G; Fortier S; Hébert SS; Kelly I; Landry CR; Faure RL
Mol Cell Proteomics; 2015 Apr; 14(4):1079-92. PubMed ID: 25687571
[TBL] [Abstract][Full Text] [Related]
36. 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.
Marsilje TH; Labroli MA; Hedrick MP; Jin Q; Desharnais J; Baker SJ; Gooljarsingh LT; Ramcharan J; Tavassoli A; Zhang Y; Wilson IA; Beardsley GP; Benkovic SJ; Boger DL
Bioorg Med Chem; 2002 Aug; 10(8):2739-49. PubMed ID: 12057663
[TBL] [Abstract][Full Text] [Related]
37. ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.
Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
[No Abstract] [Full Text] [Related]
38. The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping.
Rayl EA; Moroson BA; Beardsley GP
J Biol Chem; 1996 Jan; 271(4):2225-33. PubMed ID: 8567683
[TBL] [Abstract][Full Text] [Related]
39. Characterization of molecularly cloned human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase.
Sugita T; Aya H; Ueno M; Ishizuka T; Kawashima K
J Biochem; 1997 Aug; 122(2):309-13. PubMed ID: 9378707
[TBL] [Abstract][Full Text] [Related]
40. [The second half of de novo synthetic pathway of IMP and conversion of IMP to AMP].
Oka J
Nihon Rinsho; 2003 Jan; 61 Suppl 1():52-8. PubMed ID: 12629690
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
